ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Diabetes Mellitus, Date of authorisation: 27/09/2004, Revision: 27, Status: Authorised
Case Medical Research
◽
10.31525/cmr-e130f0
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
◽
Insulin Glulisine
Download Full-text
Related Documents
Cited By
References
Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Diabetes Mellitus, Date of authorisation: 27/09/2004, Revision: 27, Status: Authorised
Case Medical Research
◽
10.31525/cmr-e132dd
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
◽
Insulin Glulisine
Download Full-text
Human medicines European public assessment report (EPAR): Insuman, insulin human, Diabetes Mellitus, Date of authorisation: 21/02/1997, Revision: 27, Status: Authorised
Case Medical Research
◽
10.31525/cmr-133690d
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Assessment Report
◽
European Public
◽
Human Diabetes
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 19/11/2008, Revision: 16, Status: Authorised
Case Medical Research
◽
10.31525/cmr-3996de
◽
2018
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Diabetes Mellitus Type 2
◽
Diabetes Mellitus Type
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Diabetes Mellitus, Type 2, Date of authorisation: 15/11/2013, Revision: 13, Status: Authorised
Case Medical Research
◽
10.31525/cmr-116dee6
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Diabetes Mellitus Type 2
◽
Diabetes Mellitus Type
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Qtrilmet, metformin hydrochloride / saxagliptin / dapagliflozin, Diabetes Mellitus, Type 2, Date of authorisation: 11/11/2019, Status: Authorised
Case Medical Research
◽
10.31525/cmr-23f0dba
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Diabetes Mellitus Type 2
◽
Diabetes Mellitus Type
◽
Metformin Hydrochloride
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Lantus, insulin glargine, Diabetes Mellitus, Date of authorisation: 09/06/2000, Revision: 33, Status: Authorised
Case Medical Research
◽
10.31525/cmr-175590a
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Insulin Glargine
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin / sitagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 23/03/2018, Revision: 4, Status: Authorised
Case Medical Research
◽
10.31525/cmr-12043e3
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Diabetes Mellitus Type 2
◽
Diabetes Mellitus Type
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Byetta, exenatide, Diabetes Mellitus, Type 2, Date of authorisation: 20/11/2006, Revision: 22, Status: Authorised
Case Medical Research
◽
10.31525/cmr-11ef046
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Diabetes Mellitus Type 2
◽
Diabetes Mellitus Type
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Steglatro, ertugliflozin, Diabetes Mellitus, Type 2, Date of authorisation: 21/03/2018, Revision: 4, Status: Authorised
Case Medical Research
◽
10.31525/cmr-119e08a
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Diabetes Mellitus Type 2
◽
Diabetes Mellitus Type
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Eucreas, vildagliptin / metformin, Diabetes Mellitus, Type 2, Date of authorisation: 14/11/2007, Revision: 18, Status: Authorised
Case Medical Research
◽
10.31525/cmr-208eb19
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Diabetes Mellitus Type 2
◽
Diabetes Mellitus Type
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close